Novanta Inc. (NOVT)

Market Cap	4.80B
Revenue (ttm)	951.70M
Net Income (ttm)	70.62M
Shares Out	35.97M
EPS (ttm)	1.95
PE Ratio	68.37
Forward PE	37.66
Dividend	n/a
Ex-Dividend Date	n/a

Volume	225,532
Open	134.69
Previous Close	132.85
Day's Range	132.93 - 135.26
52-Week Range	98.76 - 187.12
Beta	1.45
Analysts	Hold
Price Target	160.00 (+20.0%)
Earnings Date	Aug 5, 2025

About NOVT

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• Founded: 1968
• Employees: 3,000
• Stock Exchange: NASDAQ
• Ticker Symbol: NOVT
• Website: https://www.novanta.com

Financial Performance

In 2024, Novanta's revenue was $949.25 million, an increase of 7.67% compared to the previous year's $881.66 million. Earnings were $64.09 million, a decrease of -12.06%.

Analyst Summary

According to one analyst, the rating for NOVT stock is "Hold" and the 12-month stock price target is $160.0.

Price Target

$160.0

(20.00% upside)

Analyst Consensus: Hold